Cargando...
Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19
[Image: see text] There is urgent therapeutic need for COVID-19, a disease for which there are currently no widely effective approved treatments and the emergency use authorized drugs do not result in significant and widespread patient improvement. The food and drug administration-approved drug iver...
Gardado en:
| Publicado en: | ACS Pharmacol Transl Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American
Chemical Society
2020
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724756/ https://ncbi.nlm.nih.gov/pubmed/33330844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00179 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|